Pfizer revives weight-loss medication
Pfizer is planning clinical studies for danuglipron, a once-daily weight-loss medication, after discontinuing the twice-daily version
Most Read
-
‘Kabhi Main Kabhi Tum’ finale confuses fans: Bonus episode tease?
-
Punjab closes educational institutions for all classes
-
Honda City latest price update in Pakistan
-
Parliament passes bills to increase SC judges' seats, extend term of services chiefs
-
Latest solar system prices in Pakistan – November 2024 update
-
Federal cabinet approves Hajj Policy 2025: Check out new quotas, packages
-
Red alert issued for smog in Lahore
-
Gold prices in Pakistan witness decline
-
Justice Aminuddin Khan approved as head of constitutional bench
-
Met Office forecasts huge rise in smog levels from Nov 6 to 8
-
